Marvin C. Gershengorn, M.D.

Publications

A selection of recent and significant publications can be viewed below.

Select Publications

Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.
Dougherty JP, Wolff BS, Cullen MJ, Saligan LN, Gershengorn MC.
Pharmacol Res (2017 Oct) 124:1-8. Abstract/Full Text
Multiple Transduction Pathways Mediate Thyrotropin Receptor Signaling in Preosteoblast-Like Cells.
Boutin A, Neumann S, Gershengorn MC.
Endocrinology (2016 May) 157:2173-81. Abstract/Full Text
TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.
Krieger CC, Place RF, Bevilacqua C, Marcus-Samuels B, Abel BS, Skarulis MC, Kahaly GJ, Neumann S, Gershengorn MC.
J Clin Endocrinol Metab (2016 Jun) 101:2340-7. Abstract/Full Text
Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins.
Krieger CC, Neumann S, Place RF, Marcus-Samuels B, Gershengorn MC.
J Clin Endocrinol Metab (2015 Mar) 100:1071-7. Abstract/Full Text
Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.
Marcus-Samuels B, Krieger CC, Boutin A, Kahaly GJ, Neumann S, Gershengorn MC.
Thyroid (2018 May) 28:650-655. Abstract/Full Text

Additional Publications

Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro.
Neumann S, Eliseeva E, Boutin A, Barnaeva E, Ferrer M, Southall N, Kim D, Hu X, Morgan SJ, Marugan JJ, Gershengorn MC.
J Pharmacol Exp Ther (2018 Jan) 364:38-45. Abstract/Full Text
Rebuttal to Smith and Janssen (Thyroid 2017;27:746-747. DOI: 10.1089/thy.2017.0281).
Neumann S, Gershengorn MC.
Thyroid (2017 Nov) 27:1459-1460. Abstract/Full Text
TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types.
Krieger CC, Perry JD, Morgan SJ, Kahaly GJ, Gershengorn MC.
Endocrinology (2017 Oct 1) 158:3676-3683. Abstract/Full Text
TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis.
Krieger CC, Neumann S, Marcus-Samuels B, Gershengorn MC.
Thyroid (2017 May) 27:746-747. Abstract/Full Text
Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro.
Place RF, Krieger CC, Neumann S, Gershengorn MC.
Br J Pharmacol (2017 Feb) 174:328-340. Abstract/Full Text
Thyrotropin and Insulin-Like Growth Factor 1 Receptor Crosstalk Upregulates Sodium-Iodide Symporter Expression in Primary Cultures of Human Thyrocytes.
Morgan SJ, Neumann S, Marcus-Samuels B, Gershengorn MC.
Thyroid (2016 Dec) 26:1794-1803. Abstract/Full Text
The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse.
Dougherty JP, Springer DA, Gershengorn MC.
J Vis Exp (2016 May 31) Abstract/Full Text
Abstract/Full Text